SCHEMBL1053291

SCHEMBL1053291

COc1c(C)ccc(O)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 2/20 0.41
TRPA1 O75762 1/20 0.41
HIF1A Q16665 1/20 0.41
EPAS1 Q99814 1/20 0.41
MAOA P21397 1/20 0.40
SCN5A Q14524 1/20 0.39
PDE4B Q07343 3/20 0.38
PDE4A P27815 2/20 0.38
PDE4C Q08493 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32612603 0.85 ALDH1A1 (0.43) TP53KDM4EALDH1A1LMNACYP3A4
SCHEMBL10789403 0.85 ALDH1A1 (0.43) TP53KDM4EALDH1A1LMNACYP3A4
SCHEMBL29421886 0.83 MAOA (0.44) TP53CYP3A4MAPTTDP1MAOA
SCHEMBL4294248 0.83 MAOA (0.44) TP53CYP3A4MAPTTDP1MAOA
SCHEMBL11882012 0.82 MAPT (0.48) TP53KDM4EALDH1A1LMNACYP3A4
SCHEMBL23999210 0.81 TRPA1 (0.41) TP53KDM4EALDH1A1LMNACYP3A4
SCHEMBL11750586 0.81 MAOA (0.43) TP53KDM4EALDH1A1LMNACYP3A4
SCHEMBL768018 0.81 SCN5A (0.52) TP53CYP3A4TDP1TRPA1MAOA
SCHEMBL30364533 0.79 MAPT (0.46) TP53KDM4EALDH1A1LMNACYP3A4
SCHEMBL12584714 0.79 MAPT (0.46) TP53KDM4EALDH1A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318477-B1 ADDITIVES TO PREVENT DEGRADATION OF CYCLIC ALKENE DERIVATIVES FUJIFILM ELECTRONIC MAT USA INC (US) 2019-06-05 EP disclosed
WO-2016155573-A1 HETEROCYCLIC DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE 四川海思科制药有限公司 2016-10-06 WO disclosed
US-8252704-B2 Additives to prevent degradation of cyclic alkene derivatives FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2012-08-28 US disclosed
US-20110259242-A1 Additives to Prevent Degradation of Cyclic Alkene Derivatives FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2011-10-27 US disclosed
US-7985350-B2 Additives to prevent degradation of cyclic alkene derivatives FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2011-07-26 US disclosed
EP-2318477-A1 ADDITIVES TO PREVENT DEGRADATION OF CYCLIC ALKENE DERIVATIVES FujiFilm Electronic Materials USA, Inc. (US) 2011-05-11 EP disclosed
US-20110091651-A1 Additives to Prevent Degradation of Cyclic Alkene Derivatives FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2011-04-21 US disclosed
US-7871536-B2 Additives to prevent degradation of cyclic alkene derivatives FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2011-01-18 US disclosed
WO-2010005937-A1 ADDITIVES TO PREVENT DEGRADATION OF CYCLIC ALKENE DERIVATIVES FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2010-01-14 WO disclosed
US-20090291210-A1 Additives to Prevent Degradation of Cyclic Alkene Derivatives FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2009-11-26 US disclosed
US-5019656-A Hydroxymethylation of a Phenol, Basic Catalyst, Crown Compound MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1991-05-28 US disclosed
EP-0386639-A1 Process for preparing para-hydroxybenzyl alcohol MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1990-09-12 EP disclosed
US-3970640-A Process for the production of polyphenylene ethers having a desired polymerization degree MITSUBISHI GAS CHEMICAL COMPANY, INC. (JA) 1976-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110259242-A1 Additives to Prevent Degradation of Cyclic Alkene Derivatives GPX4, GPX1, NFE2L2 TP53 1201/4885KDM4E 2810/4885ALDH1A1 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.